PHARMANUTRA PHARMANUTRA - PHN: THE BOARD OF DIRECTORS APPROVED THE DRAFT FINANCIAL STATEMENTS AND THE CONSOLIDATED FINANCIAL STATEMENTS AS AT DECEMBER 31, 2025: management transactions · Italy · Consob

Browse the full management transaction log of PHARMANUTRA PHARMANUTRA - PHN: THE BOARD OF DIRECTORS APPROVED THE DRAFT FINANCIAL STATEMENTS AND THE CONSOLIDATED FINANCIAL STATEMENTS AS AT DECEMBER 31, 2025, a listed equity based in Italy. Shares are listed on IT IT, under the supervision of Consob. Operating in the Healthcare sector, PHARMANUTRA PHARMANUTRA - PHN: THE BOARD OF DIRECTORS APPROVED THE DRAFT FINANCIAL STATEMENTS AND THE CONSOLIDATED FINANCIAL STATEMENTS AS AT DECEMBER 31, 2025 has published 1 reports. Market capitalisation: €861.8m. The latest transaction was reported on 17 March 2026 — Other. Among the most active insiders: Unknown. All data is accessible without an account.